🦊/Investors

Primavera Venture Management LimitedFull Portfolio

5 tracked investments · listed companies and verified rows first

Vitacovitacohealth.com✓ verified

Vitaco is a supplements, sports nutrition and health food company that owns and manufactures brands including Musashi, Athena, Nutra-Life and Healtheries.

ConsumerFoodTechHealthtechWellness & FitnessAuckland, NZ

Craig Kearney(Chief Executive Officer)inAndrew Folkard(Chief Commercial Officer)inJeff Peng(Chief Financial Officer)inLucinda Warren(Chief People & Culture Officer)inRoger Scott(Chief Operating Officer)in

Co-investorsNext Capital

Addenaddenenergy.com

Adden Energy develops solid-state, dynamically-stable batteries based on self-healing separator technology discovered at Harvard, aimed at fast charging, long lifetime, and non-flammable components.

CleantechDeep TechEnergyWaltham, US

William Fitzhugh(Executive Officer, Director)inLuhan Ye(Executive Officer, Director)inXin Li(Executive Officer, Director)in

BoardBernard Lupien(Director)inFred Hu(Director)inLaurie Menoud(Director)in

Co-investorsAt One VenturesMassVenturesRhapsody Venture Partners

Love, Bonitolovebonito.comOct 2021 · $50M

Love, Bonito is a direct-to-consumer fashion brand offering clothing across multiple categories including denim, tops, and staples for women.

ConsumerDirect to Consumer

Rachel Lim(Founder)in

Co-investorsOpenspace Ventures

Xbiomexbiome.com

未知君 (XBiome) develops microbiome-based therapeutics and diagnostics using AI-driven bioengineering, targeting diseases including cancer immunotherapy, inflammatory conditions, and autism through live bacterial therapeutics and fecal microbiota transplantation (FMT).

AI & Machine LearningBiotechDeep TechMedical DevicesBeijing, CN

Co-investorsGaorong CapitalHaystackMorningside Venture Capital LimitedHike CapitalLegend Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

PV Summa

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.